Mural Oncology plc
DelistedCIK 1971543fmd_1WYAQ5SG8FGZP70FG8RWPYBRHKManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2022 to Sep 30, 2025, 15 periods
| Line item | FY2022 | FY2023 | FY2024 |
|---|---|---|---|
| Research and development | 167 | 166 | 111 |
| Total operating expenses | 185 | 196 | 138 |
| Operating income | (185) | (196) | (138) |
| Other non-operating income (expense) | – | 1 | 10 |
| Income before taxes | (185) | (195) | (129) |
| Income tax expense | 5 | 12 | 0 |
| Net income from continuing operations | (190) | (207) | (129) |
| Net income | (190) | (207) | (129) |